Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-046879

VP, Clinical Trial Operations sold 3,265 shares at $23.73 ($77,478)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · VP, Clinical Trial Operations

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-18 Sale : show line 1 in the form −3,265 $23.73 $77,478 155,735 D
Open-market sales · 3,265 sh · avg $23.73 · $77,478
Loading xslF345X05/doc4.xml…